Correlation Between Karyopharm Therapeutics and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Karyopharm Therapeutics and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Centessa Pharmaceuticals.
Diversification Opportunities for Karyopharm Therapeutics and Centessa Pharmaceuticals
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Karyopharm and Centessa is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Centessa Pharmaceuticals
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Centessa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 1.64 times less risky than Centessa Pharmaceuticals. The stock trades about -0.71 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,710 in Centessa Pharmaceuticals PLC on September 26, 2024 and sell it today you would lose (20.00) from holding Centessa Pharmaceuticals PLC or give up 1.17% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Centessa Pharmaceuticals PLC
Performance |
Timeline |
Karyopharm Therapeutics |
Centessa Pharmaceuticals |
Karyopharm Therapeutics and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Centessa Pharmaceuticals
The main advantage of trading using opposite Karyopharm Therapeutics and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Centessa Pharmaceuticals vs. Fate Therapeutics | Centessa Pharmaceuticals vs. Caribou Biosciences | Centessa Pharmaceuticals vs. Karyopharm Therapeutics | Centessa Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |